Evidence map›Paper›PMID 42290800›Full record

ArticleClinical case reports2026

Symplastic Hemangioma of the Limbal Conjunctiva in a Pediatric Patient With Xeroderma Pigmentosa: A Case Report and Review of Literature.

Mahir Mahmood, Kanwal Babar, Saira Rathore, Samina Zaman, Aalaa Saleh

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahir MahmoodChughtai Institute of Pathology Lahore Pakistan.
Kanwal BabarChughtai Institute of Pathology Lahore Pakistan.
Saira RathoreChughtai Institute of Pathology Lahore Pakistan.
Samina ZamanChughtai Institute of Pathology Lahore Pakistan.
Aalaa SalehFaculty of Medicine, Lebanese University Beirut Lebanon.ORCID https://orcid.org/0009-0007-9121-6091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Symplastic hemangioma (SH) is a rare benign vascular lesion marked by striking nuclear atypia in non-endothelial stromal cells, often mimicking malignancy. It is typically seen in older adults, with only four cases reported to date. Pediatric presentations are exceedingly rare. We present a unique case of limbal SH in a 7-year-old female with xeroderma pigmentosa (XP), who presented with a pigmented conjunctival mass clinically suspected to be malignant. Given the high risk of malignancy in patients with XP-including squamous cell carcinoma and melanoma-SH can pose a diagnostic dilemma. Histological evaluation revealed a polypoidal lesion covered by stratified squamous epithelium, with numerous small blood vessels lined by plump endothelial cells and interspersed bizarre, atypical stromal cells. No necrosis, atypical mitosis, or definitive features of malignancy were identified. Immunohistochemistry showed SMA positivity in the atypical cells, confirming vascular origin, while the Ki-67 index was very low (< 1%), supporting a benign nature. These findings ruled out malignancy despite alarming histological features. To our knowledge, this is the first reported case of limbal SH in a pediatric patient with XP. This case highlights the importance of histopathological and immunohistochemical analysis in distinguishing SH from aggressive vascular tumors and avoiding unnecessary aggressive treatment. It adds valuable insight into the rare spectrum of vascular lesions in XP.

Indexed as

limbal conjunctivapediatric ocular lesionssymplastic hemangiomavascular tumorsxeroderma pigmentosa

Identifiers

PMID42290800
PMCPMC13253999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.